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Antiphospholipid syndrome is associated with endothelial dysfunction, which leads to
thrombosis and early atheroma. Given that hydroxychloroquine has anti-thrombotic
properties in lupus, we hypothesized that it could reduce endothelial dysfunction in
an animal model of antiphospholipid syndrome. We evaluated the effect of
hydroxychloroquine in preventing endothelial dysfunction in a mouse model of
antiphospholipid syndrome.
Methods
Antiphospholipid syndrome was induced by an injection of monoclonal anti-beta-2-
GPI antibodies. Vascular reactivity was evaluated in mesenteric resistance arteries
isolated from mice 3 weeks (APL3W) after receiving a single injection of anti-beta-2-
GPI antibodies and after 3 weeks of daily oral hydroxychloroquine treatment
(HCQ3W) compared to control mice (CT3W). We evaluated endothelial dysfunction by
measuring acetylcholine-mediated vasodilation. A pharmacological approach was
used to evaluate NO synthase uncoupling (tetrahydrobiopterin) and the generation of
reactive oxygen species (Tempol).
Results
Impaired acetylcholine-mediated dilation was evidenced in mice 3 weeks after anti-
beta-2-GPI antibodies injection compared to CT3W, by reduced maximal dilation
(p<0.0001) and sensitivity (pKd) (p = 0.01) to acetylcholine. Hydroxychloroquine
improved acetylcholine-dependent dilation, on pKd (p = 0.02) but not maximal
capacity compared to untreated mice. The addition of tetrahydrobiopterin (p = 0.02)
and/or Tempol (p = 0.0008) improved acetylcholine-mediated dilation in APL3W but
not in HCQ3W.
Conclusions
We demonstrated that endothelial dysfunction in mouse resistance arteries persisted
at 3 weeks after a single injection of monoclonal anti-beta-2-GPI antibodies, and that
hydroxychloroquine improved endothelium-dependent dilation at 3 weeks, through
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